Aerpio Therapeutics: Is a biopharmaceutical company focused on the development of novel therapeutics for vascular disorders with a concentration on diseases of the eye. The lead programs include a Tie2 activator for diabetic retinopathy (DR) and a hypoxia-inducible factor α (HIF-α) stabilizer for the treatment of inflammatory bowel disease. The lead compound for the Tie2 program, AKB-9778, recently completed a proof-of-concept, Phase 2a study (TIME-2). AKB-4924, the lead compound in our HIF-α stabilization program, has recently completed a Phase 1a study.
Member count: 11-50
Total raised: $98M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Montrose C... | montroseca... |
Funding Rounds 4
| Date | Series | Amount | Investors | Deal News |
| 16.03.2017 | - | $40M | - | finsmes.co... |
| 23.04.2014 | - | $22M | - | vcnewsdail... |
| 06.11.2013 | Series A | $9M | - | finsmes.co... |
| 30.08.2012 | Series A | $27M | - | vcnewsdail... |
Mentions in press and media 18
| Date | Title | Description | Category | Author | Source |
| 16.03.2017 | Aerpio Pha... | CINCINNATI--(BUSINESS WIRE)--A... | - | - | citybizlis... |
| 16.03.2017 | Aerpio Pha... | CINCINNATI--(BUSINESS WIRE)--A... | - | - | citybizlis... |
| 16.03.2017 | Biopharmac... | Aerpio Pharmaceuticals, Inc., ... | USA | - | finsmes.co... |
| 29.07.2014 | VC investm... | A number of large medical devi... | - | - | medcitynew... |
| 23.04.2014 | Aerpio The... | Aerpio Therapeutics, Inc., a C... | funding S... | - | finsmes.co... |
| 23.04.2014 | Aerpio The... | CINCINNATI, OH, Clinical-sta... | - | - | vcnewsdail... |
| 23.04.2014 | OrbiMed le... | Biopharmaceutical startup Aerp... | - | - | altassets.... |
| 07.11.2013 | Aerpio The... | CINCINNATI, OH, clinical-sta... | - | - | vcnewsdail... |
| 06.11.2013 | Aerpio The... | Aerpio Therapeutics, Inc., a C... | funding S... | - | finsmes.co... |
| 04.02.2013 | They’re no... | Westchester/New Haven The cor... | - | - | medcitynew... |
Show more